**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

Washington, D.C. 20549

**FORM 10-QSB**

**X**Quarterly report under section 13 or 15(d) of the Securities Exchange Act of 1934 for the
period ended September 30, 2003.

____Transition report under section 13 or 15(d) of the Securities Exchange Act of 1934 for the
transition period from ______ to ______.

**AGRONIX, INC.**

(Exact name of registrant as specified in its charter)

|Florida                                        | 0-15893                  | 65-0664961                          
|---------------------------------------------- | ------------------------ | ------------------------------------
|(State or other jurisdiction of
incorporation) | (Commission File
Number) | (IRS Employer Identification
Number)

|1666 West 75th Avenue

Vancouver, B.C., Canada | V6P 6G2   
|---------------------------------------------- | ----------
|(Address of principal executive offices)       | (Zip Code)

Registrant's telephone number, include area code:  (604) 714-1606

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes. X  No...

Applicable only to issuers involved in bankruptcy proceedings during the past five years.

Check whether the issuer has filed all documents and reports required to be filed by Section 12, 13 or
15(d) of the Exchange Act after the distribution of securities under a plan confirmed by a court.  Yes .....
No .....

Applicable only to corporate issuers

State the number of shares outstanding of each of the issuer's classes of common equity, as of the
latest practicable date:  At September 30, 2003, there were 24,845,590shares outstanding.

Transitional Small Business Disclosure Format (Check one):  Yes .....     No ..X..

---

PART 1 - FINANCIAL  INFORMATION

ITEM 1.  FINANCIAL STATEMENTS AND EXHIBITS ****

**AGRONIX, INC.**

****

**CONTENTS**



|                                                   | 
|-------------------------------------------------- | 
|**INTERIM CONSOLIDATED FINANCIAL STATEMENTS**      | 
|Consolidated Balance Sheets                        | 
|Interim Consolidated Statements of Operations      | 
|Interim Consolidated Statements of Cash Flows      | 
|Consolidated Statements of Stockholders' Deficit   | 
|Notes to Interim Consolidated Financial Statements | 



---

**AGRONIX, INC.**

******CONSOLIDATED BALANCE SHEETS**

**ASSETS**

|                                                  | **September
30** | ******December
31**
|------------------------------------------------- | ---------------- | -------------------
|                                                  | **2003**         | ******2002**       
|****                                              | (Unaudited)      |                    
|**CURRENT**                                       |                  |                    
|Cash                                              | $119,473         | $23,093            
|Receivables                                       | 8,770            | 22,597             
|Prepaid expenses and deposits                     | 135,429          | 15,085             
|                                                  | 263,672          | 60,775             
|**FIXED ASSETS**(Note 3)                          | 7,314            | 10,326             
|****                                              |                  |                    
|**INVESTMENT IN 3884171 CANADA INC.**(Note 4)**** | ********1****    | ********1          
|                                                  | $270,987         | $71,102            

**LIABILITIES AND STOCKHOLDERS' DEFICIT**

|**CURRENT LIABILITIES**                  |          |         
|---------------------------------------- | -------- | --------
|Accounts payable and accrued liabilities | $331,637 | $259,078
|Due to related parties (Note 5)          | 63,440   | 63,440  
|                                         | 395,077  | 322,518 
|**STOCKHOLDERS' DEFICIT**                |          |         
|**CAPITAL STOCK**(Note 6)                |          |         
|**Authorized:**                          |          |         

50,000,000 common shares with a par value of $0.001 per share

10,000,000 preferred shares with a par value of $0.001 per share

|**Issued and outstanding:**                 |                         |                    
|------------------------------------------- | ----------------------- | -------------------
|24,845,590 (2002: 20,967,981) common shares | 15,125                  | 11,247             
|Additional paid in capital                  | 4,147,514               | 2,797,610          
|Common stock subscriptions                  | 200,922                 | -                  
|****                                        | 4,363,561               | 2,808,857          
|**DEFICIT ACCUMULATED DURING THE**          | ********                | ********           
|**DEVELOPMENT STAGE**                       | ********(4,487,651)**** | ********(3,060,273)
|****                                        | (124,090)               | (251,416)          
|                                            | $270,987                | $71,102            

Continuance of operations (Note 1)

Commitments (Note 8)

See accompanying notes to the interim consolidated financial statements.

---

******AGRONIX, INC.******

**INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS**

(Unaudited)****

|****                | ******Cumulative**     | ********         | ********         | ********          | ********         
|------------------- | ---------------------- | ---------------- | ---------------- | ----------------- | -----------------
|                    | ******From Inception** | **For the Nine** | **For the Nine** | **For the Three** | **For the Three**
|                    | ******(Jan 20, 2000)** | **Months Ended** | **Months Ended** | **Months Ended**  | **Months Ended** 
|                    | **to September 30**    | **September 30** | **September 30** | **September 30**  | **September 30** 
|                    | **2003**               | ******2003**     | ******2002**     | ******2003**      | ******2002**     
|**INTEREST INCOME** | $3,544                 | $571             | $338             | $68               | $136             

|**EXPENSES**                   |           |           |         |         |        
|------------------------------ | --------- | --------- | ------- | ------- | -------
|Consulting and management fees | 2,213,400 | 740,738   | 458,017 | 164,540 | 52,442 
|Depreciation                   | 19,620    | 3,230     | 14,310  | 1,040   | 13,196 
|General and administrative     | 169,671   | 75,290    | 32,820  | 16,938  | 8,346  
|Professional fees              | 226,824   | 52,249    | 49,920  | 22,373  | 8,845  
|Rent                           | 53,294    | 11,081    | 11,824  | 2,141   | 3,537  
|Research and development       | 1,179,178 | 409,025   | 138,503 | -       | 1,263  
|Salaries and benefits          | 136,050   | 62,484    | 29,400  | 18,450  | 29,400 
|Shareholder communications     | 44,503    | 10,573    | 14,486  | 5,479   | 11,484 
|Travel and promotion           | 298,506   | 62,852    | 58,783  | 36,771  | 44,077 
|                               | 4,341,046 | 1,427,522 | 808,063 | 267,732 | 172,590

|**LOSS**before the following        | (4,337,502)             | (1,426,951)            | (807,725)              | (267,664)           | (172,454)           
|----------------------------------- | ----------------------- | ---------------------- | ---------------------- | ------------------- | --------------------
|Equity loss in 3884171 Canada Inc.  | -                       | -                      | -                      | -                   | -                   
|Loss on impairment of investment in |                         |                        |                        |                     |                     
|and advances to 3884171 Canada Inc. | (150,150)               | (429)                  | (149,721)              | (429)               | (149,721)           
|**NET LOSS FOR THE PERIOD**         | ****

**$	(4,487,652)** | ****

**$(1,427,380)** | ****

**$	(957,446)**  | **$	(268,093)**     | ****

**$(322,175)**
|****                                | ****                    | ********               | ********               | ********            | ********            
|****Weighted average common         | ****                    | ********               | ********               | ********            | ********            
|shares outstanding                  |                         | ****23,038,855****     | ********19,778,109**** | ********24,156,283  | ****20,184,915      
|****                                | ********                | ********               | ****                   | ****                | ****                
|Basic loss per share                |                         | ****$(0.06)****        | ********$(0.05)****    | ********$(0.01)**** | ********$(0.02)     



See accompanying notes to the interim consolidated financial statements.

****

****

****

****

****

---

**AGRONIX, INC.**

(A Development Stage Company)****

**INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(Unaudited)******

|********                                          | **Cumulative**         | ********         | ********            
|------------------------------------------------- | ---------------------- | ---------------- | --------------------
|****                                              | **From Inception**     | **For the Nine** | **For the Nine******
|****                                              | **(January 20, 2000)** | **Months Ended** | **Months Ended******
|****                                              | **to September 30**    | **September 30** | **September 30******
|****                                              | **2003******           | **2003******     | **2002******        
|******Cash derived from (applied to):**           |                        |                  |                     
|**OPERATING ACTIVITIES**                          | ********               | ********         | ********            
|Net Loss for the period                           | $(4,487,652)           | $(1,427,380)     | $(957,446)          
|Depreciation                                      | 19,620                 | 3,230            | 14,310              
|Non-cash research and development                 | 779,856                | 396,000          | -                   
|Stock based compensation                          | 847,100                | 169,200          | 200,900             
|Impairment of Investment in 3884171 Canada Inc.   | 149,721                | -                | 149,721             
|Wages paid through the issuance of common shares  | 55,300                 | 50,800           | 4,500               
|Rent paid through issuance of common shares       | 23,209                 | -                | 10,363              
|Consulting and legal fees paid though the         |                        |                  |                     
|issuance of common shares                         | 833,191                | 457,930          | 258,695             
|Non-cash office and general expenses              | -                      | -                | 490                 
|Change in non-cash working capital                |                        |                  |                     
|Receivables                                       | (8,770)                | 13,827           | (4,936)             
|Prepaid expense and deposits                      | (135,429)              | (120,344)        | (13,440)            
|Payables and accruals                             | 318,533                | 72,561           | 100,633             
|                                                  | (1,605,321)            | (384,176)        | (236,210)           
|**FINANCING ACTIVITIES**                          |                        |                  |                     
|Advances under a credit facility with a company   |                        |                  |                     
|with director in common, net of repayments        | 63,440                 | -                | -                   
|Consulting fees paid                              | (7,913)                | (7,913)          | -                   
|Advances from (to) shareholder                    | (14,267)               | -                | -                   
|Shares issued for cash                            | 1,659,264              | 287,763          | 262,289             
|Shares subscribed                                 | 200,922                | 200,922          | -                   
|                                                  | 1,901,446              | 480,772          | 262,289             
|**INVESTING ACTIVITIES**                          |                        |                  |                     
|Acquisition of fixed assets                       | (26,932)               | (218)            | (14,063)            
|Investment in and advances to 3884171 Canada Inc. | (149,722)              | -                | (6,705)             
|                                                  | (176,654)              | (218)            | (20,768)            
|****Increase in cash                              | 119,471                | 96,378           | 5,311               
|**Cash,** beginning of period                     | -                      | 23,093           | 100,610             
|**Cash,** end of period                           | $119,471               | $119,471         | $105,921            
|**Supplemental cash flow information:**           |                        |                  |                     
|Shares issued for research and development        | $779,856               | $396,000         | $-                  
|Stock based compensation                          | $847,100               | $169,200         | $200,900            
|Shares issued for rent                            | $23,209                | $-               | $10,363             
|Shares issued for consulting and legal services   | $833,191               | $457,930         | $258,695            
|Shares issued for wages                           | $55,300                | $50,800          | $4,500              

See accompanying notes to the interim consolidated financial statements.

---

**AGRONIX, INC.**



**CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT**



**FOR THE PERIOD FROM INCEPTION (JANUARY 20, 2000) TO SEPTEMBER 30, 2003**

|****                                        | ********         | ********     | ********         | ********       | ******Deficit** | ******** 
|------------------------------------------- | ---------------- | ------------ | ---------------- | -------------- | --------------- | ---------
|                                            |                  |              | **************** | ****           | **Accumulated** | ****     
|                                            | ******Common**   | **Common**   | **Additional**   | ****           | **During the**  | ****     
|                                            | ******Shares**   | **Shares**   | **Paid-In**      | **Shares**     | **Development** | ****     
|                                            | ******(Number)** | **(Amount)** | **Capital**      | **Subscribed** | **Stage**       | **Total**
|Shares issued for cash                      |                  |              |                  |                |                 |          
|************************at $0.001 per share | 5,250,000        | $5,250       | $-               | $-             | $-              | $5,250   
|Shares issued for cash                      |                  |              |                  |                |                 |          
|at $0.30 per share                          | 40,000           | 40           | 7,960            | -              | -               | 8,000    
|Shares issued for cash                      |                  |              |                  |                |                 |          
|at $0.50 Cdn per share                      | 1,000,000        | 1,000        | 337,287          | -              | -               | 338,287  
|Shares issued for cash                      |                  |              |                  |                |                 |          
|at $1.00 Cdn per share                      | 182,250          | 182          | 122,780          | -              | -               | 122,962  
|Shares issued to acquire                    |                  |              |                  |                |                 |          
|research and                                |                  |              |                  |                |                 |          
|development (Note 7)                        | 150,000          | 150          | 149,850          | -              | -               | 150,000  
|Shares subscribed at $1.00                  |                  |              |                  |                |                 |          
|U.S. cash per share                         | -                | -            | -                | 22,500         | -               | 22,500   
|Stock based compensation                    | -                | -            | 181,250          | -              | -               | 181,250  
|Net loss                                    | -                | -            | -                | -              | (740,239)       | (740,239)
|Balance, December 31, 2000                  | 6,622,250        | 6,622        | 799,127          | 22,500         | (740,239)       | 88,010   
|Acquisition of AWR on                       |                  |              |                  |                |                 |          
|March 26, 2001 (Note 1)                     | 6,622,250        | 6,622        | (33,990)         | -              | -               | (27,368) 
|Reverse merger adjustment                   | (4,939,000)      | (4,939)      | 4,939            | -              | -               | -        
|Shares issued at $1.00 Cdn                  |                  |              |                  |                |                 |          
|per share                                   | 669,357          | 670          | 404,543          | (22,500)       | -               | 382,713  
|Shares issued for premises                  |                  |              |                  |                |                 |          
|lease at $1.00 Cdn per                      |                  |              |                  |                |                 |          
|share                                       | 15,680           | 15           | 10,094           | -              | -               | 10,109   
|Shares issued for cash at                   |                  |              |                  |                |                 |          
|$0.50 Cdn per share                         | 231,000          | 231          | 73,196           | -              | -               | 73,427   
|Shares issued for consulting                |                  |              |                  |                |                 |          
|services at $1.00 Cdn                       |                  |              |                  |                |                 |          
|per share                                   | 442,500          | 443          | 282,627          | -              | -               | 283,070  
|Stock based compensation                    | -                | -            | 295,750          | -              | -               | 295,750  
|Net loss for the year                       | -                | -            | -                | -              | (945,584)       | (945,584)
|Balance, December 31, 2001                  | 9,664,037        | $9,664       | $1,836,286       | $-             | $(1,685,823)    | $160,127 



See accompanying notes to the interim consolidated financial statements.

---

****

(A Development Stage Company)

**CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT**



**FOR THE PERIOD FROM INCEPTION (JANUARY 20, 2000) TO SEPTEMBER 30, 2003**

|****                         | ********         | ********     | ********         | ********       | ******Deficit** | ******** 
|---------------------------- | ---------------- | ------------ | ---------------- | -------------- | --------------- | ---------
|                             |                  |              | **************** | ****           | **Accumulated** | ****     
|                             | ******Common**   | **Common**   | **Additional**   | ****           | **During the**  | ****     
|                             | ******Shares**   | **Shares**   | **Paid-In**      | **Shares**     | **Development** | ****     
|                             | ******(Number)** | **(Amount)** | **Capital**      | **Subscribed** | **Stage**       | **Total**
|                             |                  |              |                  |                |                 |          
|Balance, December 31, 2001   | 9,664,037        | $9,664       | $1,836,286       | $-             | $(1,685,823)    | $160,127 
|Shares issued for premises   |                  |              |                  |                |                 |          
|lease at $0.64 per share     |                  |              |                  |                |                 |          
|($1.00 Cdn)                  | 1,960            | 2            | 1,230            | -              | -               | 1,232    
|Shares issued for consulting |                  |              |                  |                |                 |          
|services at $0.64 per        |                  |              |                  |                |                 |          
|share ($1.00 Cdn)            | 55,000           | 55           | 35,132           | -              | -               | 35,187   
|Pre-split subtotal           | 9,720,997        | 9,721        | 1,872,648        | -              | -               | -        
|Two-for-one stock split      | 9,720,997        | -            | -                | -              | -               | -        
|Shares issued for consulting |                  |              |                  |                |                 |          
|services at $0.64 per        |                  |              |                  |                |                 |          
|share ($1.00 Cdn)            | 164,500          | 164          | 105,299          | -              | -               | 105,463  
|Shares issued for premises   |                  |              |                  |                |                 |          
|lease at $0.32 per share     |                  |              |                  |                |                 |          
|($0.50 Cdn)                  | 19,720           | 20           | 6,241            | -              | -               | 6,261    
|Shares issued for premises   |                  |              |                  |                |                 |          
|lease at $0.56 per share     |                  |              |                  |                |                 |          
|($0.85 Cdn)                  | 2,300            | 2            | 1,281            | -              | -               | 1,283    
|Shares issued for cash at    |                  |              |                  |                |                 |          
|$0.35 per share              |                  |              |                  |                |                 |          
|($0.55 Cdn)                  | 450,000          | 450          | 155,623          | -              | -               | 156,073  
|Shares issued for cash at    |                  |              |                  |                |                 |          
|$0.39 per share              |                  |              |                  |                |                 |          
|($0.60 Cdn)                  | 16,667           | 17           | 6,559            | -              | -               | 6,576    
|Shares issued for cash at    |                  |              |                  |                |                 |          
|$0.45 per share              |                  |              |                  |                |                 |          
|($0.70 Cdn)                  | 30,000           | 30           | 13,683           | -              | -               | 13,713   
|Shares issued for cash at    |                  |              |                  |                |                 |          
|$0.50 per share              | 384,000          | 384          | 191,616          | -              | -               | 192,000  
|Shares issued for cash at    |                  |              |                  |                |                 |          
|$0.75 per share              | 67,000           | 67           | 49,933           | -              | -               | 50,000   
|Shares issued for consulting |                  |              |                  |                |                 |          
|services at $1.00 per        |                  |              |                  |                |                 |          
|share                        | 100,000          | 100          | 99,900           | -              | -               | 100,000  
|Shares issued for consulting |                  |              |                  |                |                 |          
|services at $0.45 per        |                  |              |                  |                |                 |          
|share                        | 30,500           | 30           | 13,695           | -              | -               | 13,725   
|Shares issued for consulting |                  |              |                  |                |                 |          
|services at $0.40 per        |                  |              |                  |                |                 |          
|share                        | 16,000           | 16           | 6,384            | -              | -               | 6,400    
|Shares issued for consulting |                  |              |                  |                |                 |          
|services at $0.37 per        |                  |              |                  |                |                 |          
|share                        | 1,000            | 1            | 369              | -              | -               | 370      
|Balance carried forward      | 20,723,681       | $11,002      | $2,523,231       | $-             | $(1,685,823)    | $848,410 



See accompanying notes to the interim consolidated financial statements.

---

******AGRONIX, INC.**



**CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT**



**FOR THE PERIOD FROM INCEPTION (JANUARY 20, 2000) TO SEPTEMBER 30, 2003**



|****                         | ********         | ********     | ********         | ********       | ******Deficit** | ********   
|---------------------------- | ---------------- | ------------ | ---------------- | -------------- | --------------- | -----------
|                             |                  |              | **************** | ****           | **Accumulated** | ****       
|                             | ******Common**   | **Common**   | **Additional**   | ****           | **During the**  | ****       
|                             | ******Shares**   | **Shares**   | **Paid-In**      | **Shares**     | **Development** | ****       
|                             | ******(Number)** | **(Amount)** | **Capital**      | **Subscribed** | **Stage**       | **Total**  
|                             |                  |              |                  |                |                 |            
|Balance forward              | 20,723,681       | $11,002      | $2,523,231       | $-             | $(1,685,823)    | $848,410   
|Shares issued for consulting |                  |              |                  |                |                 |            
|services at $0.36 per        |                  |              |                  |                |                 |            
|share                        | 4,500            | 4            | 1,616            | -              | -               | 1,620      
|Shares issued for consulting |                  |              |                  |                |                 |            
|services at $0.34 per        |                  |              |                  |                |                 |            
|share                        | 139,000          | 139          | 47,121           | -              | -               | 47,260     
|Shares issued for consulting |                  |              |                  |                |                 |            
|services at $0.29 per        |                  |              |                  |                |                 |            
|share                        | 20,500           | 21           | 5,924            | -              | -               | 5,945      
|Shares issued for consulting |                  |              |                  |                |                 |            
|services at $0.25 per        |                  |              |                  |                |                 |            
|share                        | 16,000           | 16           | 3,984            | -              | -               | 4,000      
|Shares issued for consulting |                  |              |                  |                |                 |            
|services at $0.15 per        |                  |              |                  |                |                 |            
|share                        | 40,500           | 41           | 6,034            | -              | -               | 6,075      
|Shares issued for premises   |                  |              |                  |                |                 |            
|lease at $0.45 per share     | 2,300            | 3            | 1,032            | -              | -               | 1,035      
|Shares issued for premises   |                  |              |                  |                |                 |            
|lease at $0.40 per share     | 2,300            | 2            | 918              | -              | -               | 920        
|Shares issued for premises   |                  |              |                  |                |                 |            
|lease at $0.34 per share     | 2,300            | 2            | 780              | -              | -               | 782        
|Shares issued for premises   |                  |              |                  |                |                 |            
|lease at $0.29 per share     | 2,300            | 3            | 664              | -              | -               | 667        
|Shares issued for premises   |                  |              |                  |                |                 |            
|lease at $0.25 per share     | 2,300            | 2            | 573              | -              | -               | 575        
|Shares issued for premises   |                  |              |                  |                |                 |            
|lease at $0.15 per share     | 2,300            | 2            | 343              | -              | -               | 345        
|Shares issued for wages at   |                  |              |                  |                |                 |            
|$0.45 per share              | 10,000           | 10           | 4,490            | -              | -               | 4,500      
|Stock-based compensation     | -                | -            | 200,900          | -              | -               | 200,900    
|Net loss                     | -                | -            | -                | -              | (1,374,450)     | (1,374,450)
|Balance, December 31, 2002   | 20,967,981       | $11,247      | $2,797,610       | $-             | $(3,060,273)    | $(251,416) 



See accompanying notes to the interim consolidated financial statements.

---

****



**CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT**



**FOR THE PERIOD FROM INCEPTION (JANUARY 20, 2000) TO SEPTEMBER 30, 2003**



|****                         | ********         | ********     | ********         | ********       | ******Deficit** | ********  
|---------------------------- | ---------------- | ------------ | ---------------- | -------------- | --------------- | ----------
|                             |                  |              | **************** | ****           | **Accumulated** | ****      
|                             | ******Common**   | **Common**   | **Additional**   | ****           | **During the**  | ****      
|                             | ******Shares**   | **Shares**   | **Paid-In**      | **Shares**     | **Development** | ****      
|                             | ******(Number)** | **(Amount)** | **Capital**      | **Subscribed** | **Stage**       | **Total** 
|                             |                  |              |                  |                |                 |           
|Balance forward              | 20,967,981       | $11,247      | $2,797,610       | $-             | $(3,060,273)    | $(251,416)
|Shares issued for research   |                  |              |                  |                |                 |           
|at $0.33 per share           | 1,200,000        | 1,200        | 394,800          | -              | -               | 396,000   
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.21 per        |                  |              |                  |                |                 |           
|share                        | 25,000           | 25           | 5,225            | -              | -               | 5,250     
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.26 per        |                  |              |                  |                |                 |           
|share                        | 15,000           | 15           | 3,885            | -              | -               | 3,900     
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.27 per        |                  |              |                  |                |                 |           
|share                        | 49,500           | 50           | 13,315           | -              | -               | 13,365    
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.30 per        |                  |              |                  |                |                 |           
|share                        | 69,500           | 69           | 20,781           | -              | -               | 20,850    
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.31 per        |                  |              |                  |                |                 |           
|share                        | 25,000           | 25           | 7,725            | -              | -               | 7,750     
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.33 per        |                  |              |                  |                |                 |           
|share                        | 89,500           | 90           | 29,445           | -              | -               | 29,535    
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.34 per        |                  |              |                  |                |                 |           
|share                        | 10,000           | 10           | 3,390            | -              | -               | 3,400     
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.37 per        |                  |              |                  |                |                 |           
|share                        | 200,000          | 200          | 73,800           | -              | -               | 74,000    
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.38 per        |                  |              |                  |                |                 |           
|share                        | 40,000           | 40           | 15,160           | -              | -               | 15,200    
|Shares issued for cash       |                  |              |                  |                |                 |           
|at $0.20 per share           | 125,000          | 125          | 24,875           | -              | -               | 25,000    
|Shares issued for cash       |                  |              |                  |                |                 |           
|at $0.32 per share           | 39,186           | 39           | 12,531           | -              | -               | 12,570    
|Shares issued for cash       |                  |              |                  |                |                 |           
|at $0.34 per share           | 18,470           | 18           | 6,262            | -              | -               | 6,280     
|Shares issued for cash       |                  |              |                  |                |                 |           
|$0.35 per share              | 101,143          | 101          | 35,299           | -              | -               | 35,400    
|Common stock subscriptions   |                  |              |                  | 33,883         |                 | 33,883    
|Consulting fees paid         |                  |              | (7,913)          |                |                 | (7,913)   
|Stock-based compensation     | -                | -            | 169,200          | -              | -               | 169,200   
|Net loss                     | -                | -            | -                | -              | (881,203)       | (881,203) 
|Balance, March 31, 2003      | 22,975,280       | $13,254      | $3,605,390       | $33,883        | $(3,941,476)    | $(288,949)



See accompanying notes to the interim consolidated financial statements.

---

******AGRONIX, INC.**



**CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT**



**FOR THE PERIOD FROM INCEPTION (JANUARY 20, 2000) TO SEPTEMBER 30, 2003**



|****                         | ********         | ********     | ********         | ********       | ******Deficit** | ********  
|---------------------------- | ---------------- | ------------ | ---------------- | -------------- | --------------- | ----------
|                             |                  |              | **************** | ****           | **Accumulated** | ****      
|                             | ******Common**   | **Common**   | **Additional**   | ****           | **During the**  | ****      
|                             | ******Shares**   | **Shares**   | **Paid-In**      | **Shares**     | **Development** | ****      
|                             | ******(Number)** | **(Amount)** | **Capital**      | **Subscribed** | **Stage**       | **Total** 
|                             |                  |              |                  |                |                 |           
|Balance forward              | 22,975,280       | $13,254      | $3,605,390       | $33,883        | $(3,941,476)    | $(288,949)
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.25 per        |                  |              |                  |                |                 |           
|share                        | 24,500           | 25           | 6,100            | -              | -               | 6,125     
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.26 per        |                  |              |                  |                |                 |           
|share                        | 10,000           | 10           | 2,590            | -              | -               | 2,600     
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.29 per        |                  |              |                  |                |                 |           
|share                        | 10,000           | 10           | 2,890            | -              | -               | 2,900     
|Shares issued for legal      |                  |              |                  |                |                 |           
|services at $0.45 per        |                  |              |                  |                |                 |           
|share                        | 11,111           | 11           | 4,989            | -              | -               | 5,000     
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.46 per        |                  |              |                  |                |                 |           
|share                        | 4,500            | 5            | 2,066            | -              | -               | 2,071     
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.48 per        |                  |              |                  |                |                 |           
|share                        | 44,500           | 44           | 21,316           | -              | -               | 21,360    
|Shares issued for salary     |                  |              |                  |                |                 |           
|at $0.25 per share           | 20,000           | 20           | 4,980            | -              | -               | 5,000     
|Shares issued for salary     |                  |              |                  |                |                 |           
|at $0.46 per share           | 20,000           | 20           | 9,180            | -              | -               | 9,200     
|Shares issued for salary     |                  |              |                  |                |                 |           
|at $0.48 per share           | 20,000           | 20           | 9,580            | -              | -               | 9,600     
|Shares issued for cash       |                  |              |                  |                |                 |           
|at $0.21 per share           | 75,714           | 76           | 15,814           | -              | -               | 15,890    
|Shares issued for cash       |                  |              |                  |                |                 |           
|at $0.27 per share           | 11,629           | 12           | 3,128            | -              | -               | 3,140     
|Shares issued for cash       |                  |              |                  |                |                 |           
|at $0.29 per share           | 16,241           | 16           | 4,694            | -              | -               | 4,710     
|Shares issued for cash       |                  |              |                  |                |                 |           
|at $0.32 per share           | 117,376          | 117          | 37,443           | (22,250)       | -               | 15,310    
|Shares issued for cash       |                  |              |                  |                |                 |           
|at $0.35 per share           | 41,400           | 41           | 14,449           | (11,633)       | -               | 2,857     
|Shares issued for cash       |                  |              |                  |                |                 |           
|at $0.47 per share           | 10,414           | 10           | 4,880            | -              | -               | 4,890     
|Shares issued for cash       |                  |              |                  |                |                 |           
|at $0.51 per share           | 51,553           | 52           | 26,293           | -              | -               | 26,345    
|Shares issued for cash       |                  |              |                  |                |                 |           
|at $0.52 per share           | 9,615            | 10           | 4,990            | -              | -               | 5,000     
|Shares issued for cash       |                  |              |                  |                |                 |           
|at $0.57 per share           | 60,051           | 60           | 34,155           | -              | -               | 34,215    
|Shares issued for cash       |                  |              |                  |                |                 |           
|at $0.67 per share           | 24,328           | 24           | 16,249           | -              | -               | 16,273    
|Net loss                     | -                | -            | -                | -              | (278,083)       | (278,083) 
|Balance, June 30, 2003       | 23,558,212       | $13,837      | $3,831,176       | $-             | $(4,219,559)    | $(374,546)



See accompanying notes to the interim consolidated financial statements.

---

******AGRONIX, INC.**



**CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT**



**FOR THE PERIOD FROM INCEPTION (JANUARY 20, 2000) TO SEPTEMBER 30, 2003**



|****                         | ********         | ********     | ********         | ********       | ******Deficit** | ********  
|---------------------------- | ---------------- | ------------ | ---------------- | -------------- | --------------- | ----------
|                             |                  |              | **************** | ****           | **Accumulated** | ****      
|                             | ******Common**   | **Common**   | **Additional**   | ****           | **During the**  | ****      
|                             | ******Shares**   | **Shares**   | **Paid-In**      | **Shares**     | **Development** | ****      
|                             | ******(Number)** | **(Amount)** | **Capital**      | **Subscribed** | **Stage**       | **Total** 
|                             |                  |              |                  |                |                 |           
|Balance forward              | 23,558,212       | $13,837      | $3,831,176       | $-             | $(4,219,559)    | $(374,546)
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.20 per        |                  |              |                  |                |                 |           
|share                        | 12,000           | 12           | 2,388            | -              | -               | 2,400     
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.21 per        |                  |              |                  |                |                 |           
|share                        | 125,000          | 125          | 26,125           | -              | -               | 26,250    
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.22 per        |                  |              |                  |                |                 |           
|share                        | 214,500          | 215          | 46,975           | -              | -               | 47,190    
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.25 per        |                  |              |                  |                |                 |           
|share                        | 4,500            | 5            | 1,120            | -              | -               | 1,125     
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.26 per        |                  |              |                  |                |                 |           
|share                        | 200,000          | 200          | 51,800           | -              | -               | 52,000    
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.27 per        |                  |              |                  |                |                 |           
|share                        | 400,000          | 400          | 107,600          | -              | -               | 108,000   
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.28 per        |                  |              |                  |                |                 |           
|share                        | 14,500           | 15           | 4,045            | -              | -               | 4,060     
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.37 per        |                  |              |                  |                |                 |           
|share                        | 30,000           | 30           | 11,070           | -              | -               | 11,100    
|Shares issued for consulting |                  |              |                  |                |                 |           
|services at $0.45 per        |                  |              |                  |                |                 |           
|share                        | 10,000           | 10           | 4,490            | -              | -               | 4,500     
|Shares issued for cash       |                  |              |                  |                |                 |           
|at $0.17 per share           | 142,944          | 143          | 24,158           | -              | -               | 24,301    
|Shares issued for cash       |                  |              |                  |                |                 |           
|at $0.23 per share           | 17,174           | 17           | 3,933            | -              | -               | 3,950     
|Shares issued for cash       |                  |              |                  |                |                 |           
|at $0.26 per share           | 49,461           | 49           | 12,811           | -              | -               | 12,860    
|Shares issued for cash       |                  |              |                  |                |                 |           
|at $0.67 per share           | 7,299            | 7            | 4,883            | -              | -               | 4,890     
|Shares issued for wages      |                  |              |                  |                |                 |           
|at $0.22 per share           | 20,000           | 20           | 4,380            | -              | -               | 4,400     
|Shares issued for wages      |                  |              |                  |                |                 |           
|at $0.25 per share           | 20,000           | 20           | 4,980            | -              | -               | 5,000     
|Shares issued for wages      |                  |              |                  |                |                 |           
|at $0.28 per share           | 20,000           | 20           | 5,580            | -              | -               | 5,600     
|Common stock subscriptions   | -                | -            | -                | 200,922        | -               | 200,922   
|Net loss for the period      | -                | -            | -                | -              | (406,261)       | (406,261) 
|Balance, September 30, 2003  | 24,845,590       | $15,125      | $4,147,514       | $200,922       | $(4,625,820)    | $(262,259)



See accompanying notes to the interim consolidated financial statements.

****

********

---

****



******NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS**

**1.	OPERATIONS AND GOING CONCERN**

The company was incorporated under the laws of Florida, U.S.A. on May 6, 1996 as RCA Trading Co.
The company changed its name to Agronix, Inc. on June 18, 2001.

Pursuant to a share exchange agreement entered into on October 16, 2000 and closed on March 26, 2001,
between the shareholders of the Agronix and shareholders of a private Company, American Waste Recovery,
Inc. ("AWR"), the Company purchased all of the outstanding shares of AWR.  AWR was incorporated under
the laws of Nevada, U.S.A. on January 20, 2000 as American Bio Recovery, Inc.; on January 26, 2000, its
name was changed to American Waste Recovery, Inc.  The consideration for this acquisition was the issuance
by the company of 6,622,250 common shares.

As a result of this transaction, AWR has become a wholly-owned subsidiary of Agronix and the former
shareholders of AWR in turn became owners of the majority of the issued and outstanding shares of Agronix.
Since the former shareholders of AWR have acquired control of Agronix through this transaction, it is
considered a reverse acquisition and these financial statements are presented from the perspective of AWR
(the accounting parent in this transaction).  These financial statements present the consolidated results of
operations from AWR's date of incorporation (January 20, 2000) to September 30, 2003 including the results
of operations of Agronix since March 26, 2001.

Agronix has focused its activities on the development of its acquired technologies for commercial use, for
identifying prime international locations to build commercial plants, and forming strategic alliances for the
implementation of its global business plan.  No revenues have been realized and planned principal operations
have not yet commenced.  Agronix is engaged in the acquisition and development of technologies that
convert organic residues into agricultural products such as growth substrates, organic fertilizers, soil
amendments and chemical commodities for agriculture and industry use.

These consolidated financial statements have been prepared on the basis of a going concern, which
contemplates the realization of assets and satisfaction of liabilities in the normal course of operations.  The
Company has not generated any revenues since inception and has incurred losses since inception.  At
September 30, 2003 the Company had a working capital deficiency of $131,405 and a capital deficiency of
$124,090.  Accordingly, these factors raise substantial doubt as to the Company's ability to continue as a
going concern.  The Company's continued existence is dependent upon its ability to raise additional capital
and to ultimately achieve profitable operations.  It is management's intention to continue to pursue market
acceptance for its technological processes and to identify funding sources until such time that there is
sufficient operating cash flow to fund operating requirements.

If the going concern assumptions were not appropriate for these financial statements, then adjustments would
be necessary in the carrying values of assets and liabilities, the reported expenses and the balance sheet
classifications used.

**UNAUDITED INTERIM FINANCIAL STATEMENTS**

****	These accompanying unaudited interim consolidated financial statements have been prepared in accordance
with generally accepted accounting principles for interim financial information and conforms with
instructions to Form 10-QSB of Regulation S-B.  They may not include all information and footnotes
required by generally accepted accounting principles for complete financial statements.  However, except
as disclosed herein, there has been no material changes in the information disclosed in the notes to the
financial statements for the year ended December 31, 2002 included in the Company's Annual Report on
Form 10-KSB filed with the Securities and Exchange Commission.  The interim unaudited financial
statements should be read in conjunction with those financial statements included in the Form 10-KSB.  In
the opinion of Management, all adjustments considered necessary for a fair presentation, consisting solely
of normal recurring adjustments, have been made.  Operating results for the nine months ended September
30, 2003 are not necessarily indicative of the results that may be expected for the year ending December 31,
2003.

**CONSOLIDATION**

These consolidated financial statements are presented in U.S. dollars unless otherwise stated and
have been prepared in accordance with accounting principles generally accepted in the United
States of America and include the accounts of the Company and its wholly-owned subsidiary,
AWR.

**STOCK BASED COMPENSATION**

In December 2002, the Financial Accounting Standards Board issued Financial Accounting Standard No.
148, "Accounting for Stock-Based Compensation - Transition and Disclosure" ("SFAS No. 148"), an
amendment of Financial Accounting Standard No. 123 "Accounting for Stock-Based Compensation" ("SFAS
No. 123").  The purpose of SFAS No. 148 is to: (1) provide alternative methods of transition for an entity
that voluntarily changes to the fair value based method of accounting for stock-based employee
compensation, (2) amend the disclosure provisions to require prominent disclosure about the effects on
reported net income of an entity's accounting policy decisions with respect to stock-based employee
compensation, and (3) to require disclosure of those effects in interim financial information.  The disclosure
provisions of SFAS No. 148 were effective for the Company for the year ended December 31, 2002.  For the
nine month periods ended September 30, 2003 and 2002, proforma disclosures have not been provided as
no options were granted or vested to employees during these periods.

The Company has elected to continue to account for stock-based employee compensation arrangements in
accordance with the provisions of Accounting Principles Board Opinion No. 25, "Accounting for Stock
Issued to Employees" ("APB No. 25") and to comply with the disclosure provisions of SFAS No. 123 as
amended by SFAS No. 148 as described above.  In addition, in accordance with SFAS No. 123 the Company
applies the fair value method using the Black-Scholes option-pricing model in accounting for options granted
to consultants.  Under APB No. 25, compensation expense is recognized immediately for past services and
pro rata for future services over the option-vesting period.

The Company accounts for equity instruments issued in exchange for the receipt of goods or services from
other than employees in accordance with SFAS No. 123 and the conclusions reached by the Emerging Issues
Task Force in Issue No. 96-18, "Accounting for Equity Instruments That Are Issued to Other Than
Employees for Acquiring or in Conjunction with Selling Goods or Services" ("EITF 96-18").  Costs are
measured at the estimated fair market value of the consideration received or the estimated fair value of the
equity instruments issued for consideration other than employee services is determined on the earlier of a
performance commitment or completion of performance by the provider of goods or services as defined by
EITF 96-18.

The Company has also adopted the provisions of the Financial Accounting Standards Board Interpretation
No. 44, Accounting for Certain Transactions Involving Stock Compensation - An Interpretation of APB
Opinion No. 25 ("FIN 44"), which provides guidance as to certain applications of APB 25.  FIN 44 is
generally effective July 1, 2000 with the exception of certain events occurring afer December 15, 1998.

**FIXED ASSETS**

Fixed assets are recorded at cost less accumulated depreciation.  Depreciation is recorded on the straight-line
method at the following rates:

****

|Office equipment   | 20	% | straight line
|------------------ | ---- | -------------
|Computer equipment | 30	% | straight line
|Computer software  | 50	% | straight line

**INVESTMENTS**

****	The Company uses the equity method to account for investments in companies such as 3884171 Canada Inc.
and other business ventures over which it exercises significant influence.

**TECHNOLOGY**

The Company capitalizes the acquisition costs of technologies when their technological feasibility has been
established; otherwise such costs are charged to operations.

**RESEARCH AND DEVELOPMENT**

The Company records all research and development costs in accordance with SFAS 2 "Accounting for
Research and Development Costs".  As such, all research and development costs are expensed as they are
incurred, until such time as the research and development outcome is proven for commercial use, at which
time the costs are capitalized and amortized. To date the Company has not capitalized any development costs.

**LONG LIVED ASSETS**

The Company monitors the recoverability of long-lived assets, including fixed assets and its investments in
and advances to 3884171 Canada Inc., based on estimates using factors such as current market value, future
asset utilization, and future undiscounted cash flows expected to result from its investment or use of the
related assets.  The Company's policy is to record any impairment loss in the period when it is determined
that the carrying amount of the asset may not be recoverable.  Any impairment loss is calculated as the excess
of the carrying value over estimated realizable value.

**LOSS PER SHARE**

The Company follows SFAS No. 128 to calculate earnings (loss) per share.  Basic loss per share is computed
using the weighed effect of all common shares issued and outstanding.  Fully diluted earnings per share has
not been presented as the effect on basic earnings per share is anti-dilutive.

**USE OF ESTIMATES**

In preparing financial statements in conformity with accounting principles accepted in the United States of
America, management is required to make estimates and assumptions that affect the reported amounts of
assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial
statements for the reporting period.  Actual results may differ from those estimates.

**FOREIGN CURRENCY TRANSLATION**

The financial statements are presented in United States dollars.  In accordance with Statement of Financial
Accounting Standards No. 52, "Foreign Currency Translation", foreign denominated monetary assets and
liabilities are translated to their United States dollar equivalents using foreign exchange rates which prevailed
at the balance sheet date.  Revenue and expenses are translated at average rates of exchange during the
period.  Related translation adjustments are reported as a separate component of stockholders' equity,
whereas gains or losses resulting from foreign currency transactions are included in results of operations.

**RECENT ACCOUNTING PRONOUNCEMENTS**

SFAS 141 & 142

In July 2001, the Financial Accounting Standards Board ("FASB") issued Statement of Financial Accounting
Standards No. 141 ("SFAS 141"), "Business Combinations", which eliminates the pooling method of
accounting for business combinations initiated after June 30, 2001.  In addition, SFAS 141 addresses the
accounting for intangible assets and goodwill acquired in a business combination.  This portion of SFAS 141
is effective for business combinations completed after June 30, 2001.

In July 2001, the FASB issued Statement of Financial Accounting Standards No. 142 ("SFAS 142"),
Goodwill and Intangible Assets", which revises the accounting for purchased goodwill and intangible assets.
Under SFAS 142, goodwill and intangible assets with indefinite lives will no longer be amortized and will
be tested for impairment annually or whenever events or circumstances indicate that the estimated fair value
is less than the related carrying value as determined on a reporting unit basis.  SFAS 142 is effective for
fiscal years beginning after December 15, 2001.

SFAS 143 & 144

In July, 2001, the FASB issued SFAS No. 143, Accounting for Asset Retirement Obligations.  This statement
addresses financial accounting and reporting for obligations associated with the retirement of tangible
long-lived assets and the associated asset retirement costs.  This statement applies to all entities.  It applies
to legal obligations associated with the retirement of long-lived assets that result from the acquisition,
construction, development and / or the normal operation of a long-lived asset, except for certain obligations
of lessees.  This statement is effective for financial statements issued for fiscal years beginning after June
15, 2002.

In August 2001, the FASB issued SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived
Assets.  This statement addresses financial accounting and reporting for the impairment or disposal of
long-lived assets and supersedes FASB Statement No. 121, Accounting for the Impairment of Long-Lived
Assets to be Disposed Of.  The provisions of the statement are effective for financial statements issued for
fiscal years beginning after December 15, 2001.

The adoption of SFAS 141, 142, 143 & 144 has not had a material effect on the financial position of the
Company or on the results of its operations.

****

**3.       	FIXED ASSETS**

|****               | ********           | ********             | ******Net**          | ******Net**        
|------------------ | ------------------ | -------------------- | -------------------- | -------------------
|****               | ********           | ******Accumulated**  | ******September 30** | ******December 31**
|****               | ******Cost**       | ******Depreciation** | ******2003**         | ******2002**       
|Office equipment   | $            7,076 | $            2,335   | $            4,741   | $            5,674 
|Computer equipment | 6,644              | 4,176                | 2,468                | 4,299              
|Computer software  | 1,080              | 975                  | 105                  | 353                
|                   | $          14,800  | $            7,486   | $7,314               | $          10,326  

**4.      INVESTMENT IN AND ADVANCES TO 3884171 CANADA INC.**

Pursuant to an agreement dated March 26, 2001 entered into by the Company and Bio-Max Inc.
("Bio-Max") (a Quebec City, Canada based developer of organic waste processing plants), a
subsidiary, 3884171 Canada Inc. was created in which the Company owns 20% of the issued and
outstanding common shares and Bio-Max owns 80% of the issued and outstanding common
shares.  3884171 Canada Inc. has been established to further the development and
commercialization of Bio-Max's "Robo II" technology into Agronix/Bio-Max "Robo III"
technology [Agronix Bio-Conversion Reactor System (BCR)] using Agronix intellectual property
rights and proprietary bio-conversion formulae.

Under the terms of the agreement:

(a) Bio-Max contributed $80 Cdn and the Robo II technology as its capital contribution for an 80% interest
in 3884171 Canada Inc..  The Company contributed $20 Cdn and its technical process improvements, its
intellectual property rights and proprietary bio-conversion formulae as its capital contribution for a 20%
interest in 3884171 Canada Inc. with an option to purchase a further 30% of 3884171 Canada Inc. for
$1,500,000 CAD.  Should the Company exercise this option, it would be a 50/50 partner with Bio-Max in
3884171 Canada Inc.

(b) The Company and Bio-Max have given each other a right of first refusal to match any offer to purchase
any shares of 3884171 Canada Inc. owned by each of them.

(c) Agronix has the world licensing rights for Robo III from 3884171 Canada Inc. with the exception of the
Francophone countries.

(d) Agronix has advanced $229,000 CAD to 3884171 Canada Inc. which has completed Robo III engineering
and the Bio-Conversion Reactor System (BCR) to be licensed or sold for commercial plant operations
throughout the world.

To date, 3884171 Canada Inc. has used the funds advanced from the Company to further develop its
technology and has not yet commenced commercial operations.  Management has determined that the
recoverability of these advances cannot be reasonably assured and as a result has recorded an impairment
provision of $150,150.  The impairment provision recorded in 2003 is $429 ( 2002 - $149,721 ).

**5.       	DUE TO RELATED PARTIES**

|**** | ********                                                   | ******September 30** | ******December 31**
|---- | ---------------------------------------------------------- | -------------------- | -------------------
|     |                                                            | **********2003**     | ******2002**       
|     | Demand loan from a company controlled by a director        |                      |                    
|     | - unsecured, principal in the amount of $63,440; 12%       |                      |                    
|     | annum simple interest; interest payable monthly; repayable |                      |                    
|     | on demand or on December 31, 2003                          | $63,440              | $63,440            
|     |                                                            |                      |                    

**6.       CAPITAL STOCK**

On June 11, 2001 the Company amended its Articles of Incorporation to change the authorized
number of shares from 20,000,000 common shares to 25,000,000 and the authorized number of
preferred shares from 5,000,000 to 10,000,000.

On January 9, 2002 the company amended its outstanding number of common shares to reflect a two-for-one
split.  As a result, the 9,720,997 issued and outstanding shares as of that date changed to a total of 19,441,994
issued and outstanding shares. In addition, the company amended its Articles of Incorporation to change the
authorized number of shares from 25,000,000  to 50,000,000 common shares.  The Company has
retroactively reflected this two-for-one split in these financial statements.

**STOCK OPTIONS**

The following table summarizes information about outstanding and exercisable share options at September
30, 2003:



|**Options Outstanding** | **Options Exercisable**
|----------------------- | -----------------------

|                |                      |                       | **************Average**   | **Weighted**  | ****            | **Weighted** 
|--------------- | -------------------- | --------------------- | ------------------------- | ------------- | --------------- | -------------
|                |                      |                       | **************Remaining** | **Average**   | ****            | **Average**  
|                |                      | **********Excercise** | **Contractual**           | **Excercise** | ****            | **Excercise**
|**Number**      | ****                 | **Price**             | **Life**                  | **Price**     | **Number**      | **Price**    
|**Outstanding** | **Grant Date**       | **Per Share**         | **(In Years)**            | **Per Share** | **Exercisable** | **Per Share**
|****840,000**** | ********01/27/00**** | ********$0.25         | ****2.33                  | ****$0.25     | ****840,000     | ****$0.25    
|400,000         | 01/28/00             | 0.25                  | 2.33                      | 0.25          | 400,000         | 0.25         
|300,000         | 02/17/00             | 0.25                  | 2.39                      | 0.25          | 300,000         | 0.25         
|500,000         | 08/04/00             | 0.25                  | 2.85                      | 0.25          | 500,000         | 0.25         
|150,000         | 10/30/00             | 0.34                  | 3.08                      | 0.34          | 150,000         | 0.34         
|400,000         | 01/17/01             | 0.50                  | 2.30                      | 0.50          | 400,000         | 0.50         
|80,000          | 07/03/01             | 0.50                  | 3.76                      | 0.50          | 80,000          | 0.50         
|1,000,000       | 07/09/01             | 0.25                  | 2.78                      | 0.25          | 1,000,000       | 0.25         
|3,000,000       | 08/15/02             | 1.00                  | 3.88                      | 1.00          | 1,000,000       | 1.00         
|20,000          | 02/07/03             | 0.50                  | 5.36                      | 0.50          | 20,000          | 0.50         
|500,000         | 03/07/03             | 0.50                  | 5.44                      | 0.50          | 500,000         | 0.50         
|7,190,000       |                      |                       |                           | $0.60         | 5,190,000       | $0.45        



Summary of share option activity and information concerning options at September 30, 2003:

|**** | ******** | ********
|---- | -------- | --------

| |                              | **********Nine Months Ended**  | **Year Ended**           
| | ---------------------------- | ------------------------------ | -------------------------
| |                              | **********September 30, 2003** | ******December 31, 2002**
| | Balance, beginning of period | 6,870,000                      | 2,340,000                
| | Granted                      | 520,000                        | 1,530,000                
| | Expired                      | (200,000)                      | $-                       
| | Cancelled                    | -                              | (200,000)                
| | Balance, end of period       | 7,190,000                      | 3,670,000                

During the first quarter of 2003, the Company granted options to purchase 520,000 shares of the
Company's common stock to certain consultants at a price of $0.50 per share for a period of six
years.  Compensation expense of  $169,200 related to these options has been recorded.  The fair
value of these consultant stock options was estimated at the grant date using the Black-Scholes
option-pricing model applying the market value per share and the risk-free interest rate in effect
at the grant date of 3.14%, 204.22% volatility, and an expected life of six years.

**PERFORMANCE SHARES**

On January 27, 2000, 1,000,000 post-split performance shares were issued into escrow for the company's
President and C.E.O.  For each $0.25 of cumulative cash flow generated by the company from its operations,
two performance shares will be released from escrow.  All shares remain in escrow at September 30, 2003
and are not included in common shares issued and outstanding.

**7.       	RESEARCH AND DEVELOPMENT**

During 2000, AWR acquired certain soil and organic matter expertise and intellectual property
from an unrelated organic residue consultant based in Ottawa, Canada.  The consideration for
this acquisition was 300,000 post-split AWR common shares issued at an estimate of their fair
value of $0.50 per share. This research and development acquired has yet to be proven
commercially and its cost of acquisition was expensed.

During 2001, 220,000 post-split Agronix shares were issued at an estimate of their fair value of $0.32 per
share ($0.50 Cdn) to three separate parties with soil science and engineering expertise.  The shares were
consideration for engineering activity which was required to advance the design of the BCIR system to the
point that it meets specific functional, manufacturing and economic requirements.

A further 500,000 post-split shares were issued during 2001 at an estimate of their fair value of $0.32 per
share ($0.50 Cdn) to three separate parties with soil science and engineering expertise.  The shares were
consideration for routine, on-going efforts to refine, enrich, and otherwise improve upon the qualities of the
existing BCR system, and the engineering follow-through to commercial production.

**British Columbia Bio Ventures (BCBV)**

On September 1, 2002, the Company entered into a consulting agreement with BCBV whereby the Company
agreed to pay a minimum of $10,000 Cdn. per month for a period of 36 months.  At that time the Company
and its President also agreed that the President would transfer his 1,000,000 performance shares to the
consultants.  These shares were not transferred.  On March 7, 2003 the September 1, 2002 agreement was
terminated and the intended transfer of the 1,000,000 performance shares was cancelled.  A new agreement
dated March 7, 2003 was entered into whereby Agronix purchased from BCBV the rights to their intellectual
and technological properties and technical systems and processes in exchange for 1,200,000 common shares
at an estimate of their fair value of $0.33 per share for a total of $396,000 and 500,000 share options at $0.50
to be divided between the two principals of BCBV.  Under the terms of the agreement, Agronix has agreed
that BCBV will manage the new Operations Division of Agronix.

The company has incurred research and development expenses as follows:

|****                                                    | ******Cumulative**     | ******For the**  | ******For the** 
|------------------------------------------------------- | ---------------------- | ---------------- | ----------------
|                                                        | **From Inception**     | **Nine Month**   | **Nine Month**  
|                                                        | **(January 20, 2000)** | **Period Ended** | **Period Ended**
|                                                        | **to September 30**    | **September 30** | **September 30**
|                                                        | **2003******           | ******2003****** | ******2002**    
|Acqusition of organic matter expertise and intellectual |                        |                  |                 
|property                                                | $164,500               | $-               | $-              
|Technical development of BCR System                     | 333,501                | 4,558            | 137,240         
|Technical development of BCIR System                    | 285,177                | 8,467            | -               
|BCBV intellectual property, systems and processes       | 396,000                | 396,000          | -               
|                                                        | $1,179,178             | $409,025         | $137,240        

**8.       COMMITMENTS**

**Collaborative Research and Development Agreement**

The Company has consolidated its research and development activities at Carleton University in Ottawa,
Canada where pursuant to an agreement (the "Agreement") effective May 1, 2001 and as amended July 17,
2001, the Company has committed to fund a maximum of approximately $440,000 towards certain projects
over the four year period ending April 30, 2005.  Under the terms of the Agreement interest accrues at 1.5%
per month on Carleton's invoices that are not paid within 30 days.

The Company will own any new technologies and/or intellectual property arising out of these research and
development activities.  Carleton will have the right to (a) a royalty free non-exclusive license for research
and educational purposes; (b) a reasonable royalty on any commercially exploitable projects; and (c) in the
event the Company does not exploit the projects within a specified time to be agreed upon, the right to
commercially exploit them shall be reassigned to Carleton University, subject to a royalty-free non-exclusive
license to the Company.  To date the Company has incurred $211,019 for research and development and
$35,698 in accrued interest on its outstanding liability to Carleton.

The research and development agreement has been discontinued until such a time that the Company is able
to satisfy its obligation to Carlton University.

**Licensing Agreement**

The Company has entered into a licensing agreement dated February 28, 2003 with a private Jamaican
registered company whereby the Company has committed to provide exclusive rights to introduce the
Company's technology throughout the Caribbean (Caricom region).  Under the agreement the Company has
received a promissory loan note, the principal amount of $2,500,000; non-interest bearing and expiring on
August 31, 2003. The note has been extended to December 31, 2003.

This transaction has not been recorded in the financial statements, as there is uncertainty as to the
collectibility of the $2,500,000 note.

**Consulting Agreement**s

The Company has entered into certain consulting agreements whereby the Company has committed to issue
a total of 14,500 shares per month to consultants for each month of service provided subject to monthly
renewals.

The Company has entered into an agreement whereby the Company has agreed to pay a transaction fee of
up to 10% of the transaction value of any contracts arising from introductions to prospective contacts.

**Executive Employment Agreement**

The Company has entered into an executive employment agreement effective August 15, 2002 whereby the
Company has agreed to pay $20,000 per month if and when those funds are available to its C.E.O for a period
of sixty months.  The Company may issue up to 20,000 shares in lieu of salary any months where the funds
are not available.  The Company must pay four months salary on termination.  Under the terms of this
agreement the Company also granted stock options to the C.E.O. providing the right to acquire 3,000,000
shares of common stock at $1.00 per share for a period of five years. (See Note 6.)

**TERRALIFT U.K. LTD. / ORGANIC WASTE RETURNS LTD.**

The Company entered into a Letter of Intent with Organic Waste Returns Ltd. ("OWR") dated January 7,
2003 whereby it had committed to acquire an 82% interest in a private Ireland registered company (OWR)
for $1,500,000 cash and $1,000,000 worth of common stock.  Under a separate Letter of Intent, OWR would
aquire 100% of Terralift U.K. Ltd.  Agronix would effectively be acquiring 82% of OWR, which would
acquire 100% of Terralift.  The Letter of Intent had an initial expiry date of January 31, 2003 but has been
extended to August 31, 2003.

On September 22, 2003 the company signed a formal agreement with OWR and Terralift U.K. Ltd. which
called for a deposit of $50,000 which had not been paid as at September 30, 2003.  The Company has 90 days
from the date of signing this agreement to close on the agreement.

BCBV has been a consultant to Agronix since 2002.  Subsequent to negotiating the letter of intent, BCBV
has become an "insider" through the Agronix acquisition of BCBV's intellectual property and technical
processes.  Subsequently, those principals of BCBV may benefit from certain payments and shareholdings
derived from the Agronix acquisition of Terralift/OWR, and could be perceived to be a conflict of interest.
The Agronix Board of Director's will seek legal opinion prior to the formal closing of this contract.

As well, under a separate letter of intent the Managing Director of Terralift shall be granted a stock option
of Five Hundred Thousand (500,000) Agronix, Inc. shares issued quarterly from the date of closing, at market
value, over 2 (two) years, for a consulting agreement to develop residual products from Agronix processing
facilities.

**9.       INCOME TAXES**

At September 30, 2003, the company has net operating losses carried forward of approximately
$2,700,000 that may be offset against future taxable income to 2023.  No future tax benefit has
been recorded in the financial statements, as the Company believes that it is more likely than not
that the carryforwards will expire unused between the 2018 and 2023 taxation years.
Accordingly, the potential tax benefits of the loss carry-forwards are offset by a valuation
allowance of the same amount.

**10.       RELATED PARTY TRANSACTIONS**

During the nine month period ended September 30, 2003, the Company paid $100,825 in salary
and consulting fees to its president and C.E.O. including cash payments of $50,025 and 160,000
common shares valued at $50,800.  The Company also paid $552,618 to certain officers and
other shareholders as legal and consulting fees comprised of cash payments of $94,688 and
1,598,611 common shares valued at $457,930.  The Company paid 1,200,000 common shares
valued at $396,000 for research and development to BCBV as disclosed in note 7.



---

**ITEM 2. 	MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF
 		OPERATION**

The following discussion contains certain statements that may constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any
statements that refer to expectations, projections or other characterization of future events or
circumstances, and especially those which include variations of the words "believes," "intends,"
"estimates," "anticipates," "expects," "plans," or similar words or variations thereof, are likely to
be forward-looking statements, and as such, are likely to concern matters involving risk,
uncertainty, unpredictability and other factors that could materially and adversely affect the
outcome or results indicated by or inferred from the statements themselves. Therefore, the reader
is advised that the following discussion should be considered in light of the discussion of risks
and other factors contained in this Form 10QSB and in the Company's other filings with the
Securities and Exchange Commission, and that no statements contained in the following
discussion or in this Form 10QSB should be construed as a guarantee or assurance of future
performance or future results.

**Introduction**

During the second quarter 2001, the Company held a special shareholders' meeting, which
approved a name, change from RCA Trading Co. d.b.a. American Waste Recovery, Inc. to
Agronix, Inc. This name change complements the market/industry in which the Company does
business. At that time, the number of authorized shares of common stock of the Company was
voted to be increased from 10,000,000 to 25,000,000, and 10,000,000 shares of preferred stock
were also authorized. In January 2002, in conjunction with a 2:1 forward split of its issued and
outstanding common stock, the Company increased its authorized common stock from
25,000,000 to 50,000,000 shares.

**Plan of Operations**

Agronix, Inc. is in the business of acquiring and developing technologies that convert organic
wastes (animal manure, sewage sludge, bio-solids, produce processing waste, etc.) into
agricultural products such as growth substrates, organic fertilizer, soil amendments and other
value added agri-products. The Company is also engaged in the business of developing a
technology that is used to recover chemical commodities from organic waste for a wide variety of
industries such as agriculture, food, oil & gas, paper, clothing and pharmaceuticals. The
Company's Bio-Conversion Reactor System (BCR System) is now fully engineered and ready to
enter the market. The Company has located 3 permitted locations in North America and Europe
to launch its first plant.

The Company remains in the development stage and does not have an established source of
revenue sufficient to cover its operating costs. As of September 30, 2003, the Company had cash
on hand of $119,473, which is not sufficient to allow it to pay its operating expenses and carry
out its plan of operation for the next twelve months. Therefore, it is the Company's intention to
seek additional financing through private and public placements of its common stock and to seek
commercial alliances and begin production where market opportunities exist.

The Company experienced a net loss of $1,427,380 for the nine months ended September 30,
2003, compared with a loss of $957,446 for the same period last year. The loss for the nine
months ending September 30, 2003 is approximately $469,934 more than the loss for the same
period of 2002. The difference is primarily due to stock based compensation for consulting and
management, and research and development costs that weren't realized in 2002.  Pursuant to an
agreement entered into by the Company and BIOMAX Inc., a Canadian company located in
Quebec City (a developer of automated organic waste processing plants), the Company and
Biomax have created a subsidiary 3884171 Canada Inc. ("Newco") to further develop and
commercialize Biomax's "Robo III" technology by combining the Robo III technology with the
Agronix proprietary technology. In exchange for its technology contribution, Biomax has an 80%
interest in Newco, and for its cash contribution of $229,000 CAD, intellectual property and
proprietary soil science expertise Agronix has received exclusive licensing rights and a 20%
equity interest. Agronix has the right to purchase a further 30% equity interest over the next 3
years for $1,500,000 CAD. The asset in Newco has been expensed as per US GAAP rules;
however, this accounting change has no material affect on the acquisition of the technology
acquired by Agronix, Inc. and the related contracts.

Agronix has specifically focused on negotiating joint venture Bio-Conversion Reactor System
(BCR) plants in the following jurisdictions:

Europe - Ireland

Canada - Alberta, British Columbia and Quebec.

The Company has entered into discussions with the Farm Credit Corporation (FCC) of Canada to
provide 75% financing for plants to be constructed in Canada, but there is no assurance that this
funding will be available. 100% financing is available through the FCC provided the Company
partners with members of the Agriculture community.

The Company has its research and development activities at Carleton University in Ottawa where
it has committed to fund research being carried out by Carleton University for a period of 5 years.
The Company will own any new technologies and/or intellectual property arising out of these
research and development activities.

There are no assurances that the Company can continue to meet its financial obligations without
a major funding. The Company has been able to cover its overhead and general administrative
cost by selling private placements. These funds have been sufficient to cover day-to-day
operational costs.

During the third quarter of 2003 the Company focused on raising capital for the acquisition of a
facility in Ireland. It has been in Ireland with financing partners reviewing the technology and
facility, which the company intends to acquire prior to the end of the year.

The Company entered into a LOI with Organic Waste Returns, Ltd., dated January 7, 2003
whereby it had committed to acquire an 82% interest in the private Ireland registered company
(OWR) for $1,500,000 cash and $1,000,000 worth of common stock.  Under a separate Letter of
Intent, OWR would acquire 100% of Terralift U.K. Ltd.  Agronix would effectively be acquiring
82% of OWR, which owns 100% of Terralift.  The letter of intent had an initial expiry date of
January 31, 2003 but had been extended to August 31, 2003.  Under the Letter Of Intent, Agronix
would purchase 82% of Organic Waste Returns Ltd. (OWR).

On September 22, 2003 the company signed a formal agreement with OWR and Terralift U.K.
Ltd, which included a deposit of $50,000. The company has 90 days from the date of signing this
agreement to close on the agreement.

In addition, Dave Roberts and Dale Fehr have joined the Agronix team.  Mr. Roberts and Mr.
Fehr will provide the Company with due diligence for the acquisitions of profitable targeted sites
as they relate to the BCR & BCIR Systems.

The addition of Dave Roberts and Dale Fehr of BC BioVentures is in keeping with the direction
of the Company's business plan and mission statement. Recognizing the change in market
conditions and implementing the Company's technologies through partnering in existing
facilities is intended to bring revenue into the Company in a more efficient and cost effective
manner.

The signed agreement for the Castleblayne, Ireland plant is a significant step forward for the
company in that it will provide immediate revenues for the company upon closing.



The Company is working with strategic partners globally, which could result in advancements for
the Company for the balance of this year and well into 2004.

The Company's shares are listed for trading on the OTC Bulletin Board under the symbol
"AGNI."

******ITEM 3.		CONTROLS AND PROCEDURES**

The Company's Chief Executive Officer and Chief Financial Officer (or those persons
performing similar functions), after evaluating the effectiveness of the Company's disclosure
controls and procedures (as defined in Rules 13a-14(c) and 15d-14(c) under the Securities
Exchange Act of 1934, as amended) as of a date within 90 days before the filing date of this
quarterly report (the "Evaluation Date"), have concluded that, as of the Evaluation Date, the
Company's disclosure controls and procedures were effective to ensure the timely collection,
evaluation and disclosure of information relating to the Company that would potentially be
subject to disclosure under the Securities Exchange Act of 1934, as amended, and the rules and
regulations promulgated thereunder. There were no significant changes in the Company's internal
controls or in other factors that could significantly affect the internal controls subsequent to the
Evaluation Date.

******PART II**

**ITEM 1.  LEGAL PROCEEDINGS**

None.****

**ITEM 2.   CHANGES IN SECURITIES AND USE OF PROCEEDS**

During the quarter ended September 30, 2003, the Company issued a total of 1,287,378
shares. A total of 276,878 of these shares were issued for cash in transactions which were made
in reliance upon exemptions from registration under the Securities Act of 1933.  The gross
offering proceeds received from the sale of such shares was $61,001, and the Company paid no
underwriting discounts or commissions.  The shares were issued in reliance upon the safe harbor
provisions of Regulation S, adopted under the Securities Act of 1933, for offers and sales that
occured outside the United States.  The shares were issued on various dates between July 1, 2003
and September 30, 2003, to persons who subscribed for purchase of such shares pursuant to the
terms of an offering memorandum dated April 30, 2003.

******ITEM 3.	DEFAULTS UPON SENIOR SECURITIES**

None.

******ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS**

None.

******ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K.**

31.1 	Certifications pursuant to Rule 13a-14(a) or 15d-14(a) under theSecurities
Exchange Act of 1934, as amended.

32.1 	Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant toSection
906 of the Sarbanes-Oxley Act of 2002.

(b)	No reports on Form 8-K were filed by the Company for the quarter ended
September 30, 2003.

****

---

**SIGNATURES**

In accordance with the requirements of the Exchange Act, the registrant caused this report
to be signed on its behalf by the undersigned, thereunto duly authorized.

**AGRONIX, INC.**

By:/S/ PETER DRUMMONDPeter Drummond,Chairman and Chief Executive Officer



By: /S/ BRIAN HAUFFBrian Hauff, President, Chief Financial Officer and a Director

By:/S/ PETER J. BARNETTPeter J. Barnett, Director



Date:   November 14,  2003

---

**31.1 Certification pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange
Act of 1934, as amended**

I, Peter Drummond, certify that:

I have reviewed this quarterly report on Form 10-QSB of Agronix, Inc.

Based on my knowledge, this report does not contain any untrue statement of a material fact or
omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by
this report;

Based on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the company as of, and for, the periods presented in this report;

The company's other certifying officer(s) and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls
and procedures to be designed under our supervision, to ensure that material information relating
to the company, including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the company's disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the company's internal control over financial
reporting that occurred during the period covered by the annual report that has materially
affected, or is reasonably likely to materially affect, the company's internal control over financial
reporting; and

The company's other certifying officer(s) and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the company's auditors and the audit
committee of the company's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect the
company's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees
who have a significant role in the company's internal control over financial reporting.



|Date:	November 14, 2003 | By:/S/ PETER DRUMMONDPeter Drummond, Chairman and Chief Executive Officer
|----------------------- | -------------------------------------------------------------------------

---

**31.1 	Certification pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange
Act of 1934, as amended**

I,Brian Hauff, certify that:

I have reviewed this quarterly report on Form 10-QSB of Agronix, Inc.

Based on my knowledge, this report does not contain any untrue statement of a material fact or
omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by
this report;

Based on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the company as of, and for, the periods presented in this report;

The company's other certifying officer(s) and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls
and procedures to be designed under our supervision, to ensure that material information relating
to the company, including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the company's disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the company's internal control over financial
reporting that occurred during the period covered by the annual report that has materially
affected, or is reasonably likely to materially affect, the company's internal control over financial
reporting; and

The company's other certifying officer(s) and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the company's auditors and the audit
committee of the company's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect the
company's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees
who have a significant role in the company's internal control over financial reporting.
Date:	November 14, 2003
By:/S/ BRIAN HAUFF

Brian Hauff, Chief Financial Officer and Director

---

**32.1  Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002**

In connection with the Quarterly Report of Agronix, Inc. (the "Company") on Form 10-QSB for the period ending September 30, 2003, as filed with the Securities and Exchange
Commission on the date hereof (the "Report"), I, Peter Drummond, Chief Executive Officer and
Chairman of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906
of the Sarbanes-Oxley Act of 2002, that:(1) The Report fully complies with the requirements of
section 13(a) or 15(d) of the Securities Exchange Act of 1934; and(2) The information contained
in the Report fairly presents, in all material respects, the financial condition and results of
operations of the Company.

By:/S/ PETER DRUMMONDPeter Drummond, Chairman and Chief Executive Officer

Date:  November 14, 2003****

---

**32.1** **Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002**

In connection with the Quarterly Report of Agronix, Inc. (the "Company") on Form 10-QSB for the period ending September 30, 2003, as filed with the Securities and Exchange
Commission on the date hereof (the "Report"), I, Brian Hauff, Chief Financial Officer and a
Director of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906
of the Sarbanes-Oxley Act of 2002, that:(1) The Report fully complies with the requirements of
section 13(a) or 15(d) of the Securities Exchange Act of 1934; and(2) The information contained
in the Report fairly presents, in all material respects, the financial condition and results of
operations of the Company.

By:/S/ BRIAN HAUFFBrian Hauff, Chief Financial Officer and Director

Date: November 14, 2003